PulsePoint Randomized Controlled Trial: Evaluating the PulsePoint mobile device application to increase bystander resuscitation for victims of sudden cardiac arrest
PI: Steven Brooks
Summary: The PulsePoint mobile device application (www.pulsepoint.org) empowers CPR-trained citizens to respond and provide basic life support to nearby suspected cardiac arrest emergencies while professional crews are being dispatched. When a mobile device receives the alert data from the PulsePoint system, the application presents a map showing the exact location of the emergency and the closest public access defibrillator. A multi-centre randomized controlled trial will be launched imminently to determine whether the PulsePoint system increases bystander CPR or defibrillator use compared to standard dispatch procedures for patients who suffer non-traumatic, out-of-hospital cardiac arrest in public locations. We have been awarded a Canadian Institutes of Health Research grant to conduct the trial, which will launch in 2019 with an anticipated accrual of two years.